Nom du produit:L161982

IUPAC Name:N-{[4'-({3-butyl-5-oxo-1-[2-(trifluoromethyl)phenyl]-4,5-dihydro-1H-1,2,4-triazol-4-yl}methyl)-[1,1'-biphenyl]-2-yl]sulfonyl}-3-methylthiophene-2-carboxamide

CAS:147776-06-5
Formule moléculaire:C32H29F3N4O4S2
Pureté:98%
Numéro de catalogue:CM505753
Poids moléculaire:654.72

Unité d'emballage Stock disponible Prix($) Quantité
CM505753-50mg in stock ŤŤƥǙ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:147776-06-5
Formule moléculaire:C32H29F3N4O4S2
Point de fusion:-
Code SMILES:O=C(C1=C(C)C=CS1)NS(=O)(C2=CC=CC=C2C3=CC=C(CN4C(CCCC)=NN(C5=CC=CC=C5C(F)(F)F)C4=O)C=C3)=O
Densité:
Numéro de catalogue:CM505753
Poids moléculaire:654.72
Point d'ébullition:
N° Mdl:MFCD09959710
Stockage:Keep in dark place,Sealed in dry,2-8°C.

Category Infos

Triazoles
Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.

Related Products